Last edition
News about "CHMP review"
European Medicines Agency Recommends Ending Use of Tecovirimat SIGA for Mpox Treatment
CHMP review finds no clinical benefit in mpox patients, while other approved uses of the antiviral remain unaffected.
CHMP Review | 30/03/2026 | By News Bureau | 107
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members